Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
SAN CARLOS, Calif., April 13, 2023 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a…
SAN CARLOS, Calif., April 13, 2023 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a…
LONDON, April 13, 2023 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or…
LONDON, April 13, 2023 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or…
BOSTON, April 13, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company…
BOSTON, April 13, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company…
Bagsværd, Denmark, 13 April 2023 – Novo Nordisk today announced the sales and operating profit…
Bagsværd, Denmark, 13 April 2023 – Novo Nordisk today announced the sales and operating profit…
Presentation of data for the mechanism underlying HCW9218 against solid tumors HCW9218 is the clinical-stage,…
Presentation of data for the mechanism underlying HCW9218 against solid tumors HCW9218 is the clinical-stage,…
Streamlining Phase 3 Fibromyalgia and Phase 2 Chronic Migraine Trials by Eliminating Interim Analyses Topline…
Streamlining Phase 3 Fibromyalgia and Phase 2 Chronic Migraine Trials by Eliminating Interim Analyses Topline…
CAMBRIDGE, Mass., April 13, 2023 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader…
CAMBRIDGE, Mass., April 13, 2023 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader…
Long COVID remains a high unmet need causing a myriad of complications for patients and…
Long COVID remains a high unmet need causing a myriad of complications for patients and…
Clinical data on the compassionate use of B-VEC to treat a RDEB patient, with recurrent…
Clinical data on the compassionate use of B-VEC to treat a RDEB patient, with recurrent…
NEW YORK and BERLIN, April 13, 2023 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai”),…
NEW YORK and BERLIN, April 13, 2023 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai”),…
Recent upgrades lead to testing results that show Verizon customers have the best network experience…